Campbell Jeffrey, Chan Garson, Luke Patrick P
Schulich School of Medicine and Dentistry and Department of Surgery, Division of Urology, Western University, London, ON, Canada.
Can Urol Assoc J. 2017 Jul;11(7):E261-E265. doi: 10.5489/cuaj.4166. Epub 2017 Jul 11.
Intraoperative warm ischemic time (WIT), associated with hilar clamping during partial nephrectomy (PN), is an established modifiable risk factor for renal dysfunction. We assessed early clamp release (ECR) as a strategy to reduce WIT and assess its impact on renal function and bleeding.
We retrospectively assessed patients who underwent minimally invasive PN by a single surgeon at our centre since December 2011. Comparing the standard technique to an ECR modification, WIT, complications, change in estimated glomerular filtration rate (eGFR), and change in differential function as demonstrated by MAG-3 nuclear renography were assessed. Followup blood work and renograms were performed at 6-12 weeks postoperatively and compared to baseline in 70 patients (35 ECR: 35 control).
The ECR and control groups were similar in age, sex, and tumour size, with only patient weight being higher in the ECR group (91.6 vs. 81.6 kg; p<0.05). WIT was significantly lower in ECR group compared to control (18.8 vs. 31.5 minutes; p<0.05). Although there was no significant difference in change from baseline eGFR in the early postoperative period (Day 3) or in followup (6-12 weeks), the control group had a significantly greater loss of ipsilateral renal function from baseline compared to the ECR group (9 vs. 4% change; p<0.05). Blood loss and complication rate were similar between groups.
The ECR technique offers a safe, reproducible alternative that reduces WIT during laparoscopic PN. ECR demonstrates a reduction in overall ipsilateral renal dysfunction, without increasing complication or intraoperative bleeding risk.
术中热缺血时间(WIT)与部分肾切除术(PN)期间的肾门阻断相关,是已确定的可改变的肾功能障碍危险因素。我们评估了早期阻断释放(ECR)作为减少WIT的策略,并评估其对肾功能和出血的影响。
我们回顾性评估了自2011年12月以来在我们中心由单一外科医生进行微创PN的患者。将标准技术与ECR改良技术进行比较,评估WIT、并发症、估计肾小球滤过率(eGFR)的变化以及MAG-3核素肾图显示的分肾功能变化。在70例患者(35例ECR组:35例对照组)术后6-12周进行随访血液检查和肾图检查,并与基线进行比较。
ECR组和对照组在年龄、性别和肿瘤大小方面相似,仅ECR组患者体重较高(91.6 vs. 81.6 kg;p<0.05)。与对照组相比,ECR组的WIT显著更低(18.8 vs. 31.5分钟;p<0.05)。虽然术后早期(第3天)或随访(6-12周)时与基线eGFR的变化无显著差异,但与ECR组相比,对照组同侧肾功能从基线的损失显著更大(变化9% vs. 4%;p<0.05)。两组间失血量和并发症发生率相似。
ECR技术提供了一种安全、可重复的替代方法,可减少腹腔镜PN期间的WIT。ECR显示总体同侧肾功能障碍有所减少,而不增加并发症或术中出血风险。